: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
Martelli, Maria Paola;
2025
Abstract
: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
